Animal models for the atherosclerosis research: a review

Li, Xiangdong; Liu, Yuanwu; Hua, Zhen; Ren, Liming; Li, Qiuyan; Li, Ning

doi:10.1007/s13238-011-1016-3

Cited by 124 publications

(97 citation statements)

References 110 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our previous study, we found that Endostar could inhibit neovascularization and plaque growth in the rabbit model of AS 23) . However, vasa vasorum in rabbits or mice is thinner than in porcine and human arteries 37) . In this swine model of AS, we found that the density of vasa vasorum and IMT in the AS Endostar group was markedly less than that in the AS group.…”

mentioning

confidence: 90%

Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model

Xu¹,

Mao²,

Chai

et al. 2015

J Atheroscler Thromb

View full text Add to dashboard Cite

Aim:Vasa vasorum neovascularization is a key feature of atherosclerosis (AS) and is strongly associated with inflammatory infiltration, lipid deposition, intraplaque hemorrhage, and hemosiderin deposit. Here we investigate the effects of Endostar, a strong anti-angiogenic drug, on vasa vasorum neovascularization in the experimental porcine model of early AS. Methods: Eighteen adult male Ba-Ma mini pigs were randomized into three groups, with six animals in each group. The pigs in the normal (N) group were fed a normal diet for 18 weeks, without balloon injury surgery. The animals in the atherosclerotic (AS) control and AS Endostar groups were fed a hypercholesterolemic diet for 12 weeks after balloon injury surgery; they received either saline or Endostar for an additional six weeks, while continuing the hypercholesterolemic diet. The atherosclerotic abdominal aorta and levels of serum lipids, TNF-alpha, IL-6, and hs-CRP were analyzed at 18 weeks. Results: The AS group had a significantly higher body weight and serum lipid concentration levels than the N group (p 0.05), confirming the success of the hypercholesterolemic diet. However, no statistical differences were noted between the AS and AS Endostar groups. Histopathology results revealed that vasa vasorum density and intima -media thickness (IMT) had also increased in the AS group compared with those in the N group (p 0.05). The Endostar treatment significantly alleviated AS with decreased vasa vasorum density and IMT (AS vs. AS Endostar, p 0.05). Western blot analysis indicated that the expression of VEGF, -catenin, and TNF-alpha in the atherosclerotic abdominal aorta was considerably reduced by the Endostar treatment. In addition, immunohistochemistry results showed that the angiogenesis markers VEGF and -catenin were predominately localized in endothelial cells of the adventitial vasa vasorum. The levels of the serum inflammatory markers TNF-alpha, hs-CRP, and IL-6 were markedly higher in the AS group than in the N group (p 0.05) but showed no marked difference during the Endostar treatment, suggesting that the local inhibition of angiogenesis was not accompanied by a change in serum inflammatory markers and that the inhibitive effect of Endostar on local TNF-alpha expression could be because of the prevention of vasa vasorum neovascularization. Conclusions: Our results demonstrated that the Endostar treatment inhibited vasa vasorum neovascularization and AS progression in the experimental porcine model of early AS, supporting the role of vasa vasorum neovascularization in the development of AS and the therapeutic potential of antiangiogenesis intervention in AS.

show abstract

mentioning

confidence: 90%

Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model

Xu¹,

Mao²,

Chai

et al. 2015

J Atheroscler Thromb

View full text Add to dashboard Cite

show abstract

“…Since then, a number of animal models have been used to explain the relationship between disorders of lipid metabolism and atherogenesis (see reviews [108,109]). In this sense, dietary lipid manipulation and use of naturally defective animals, such as Watanabe heritable hyperlipidemia (WHHL) rabbits, have been the focus of most experimental settings (see chapter 22).…”

Section: The Rabbit Modelsmentioning

confidence: 99%

Animal Models as Tools for Translational Research: Focus on Atherosclerosis, Metabolic Syndrome and Type-II Diabetes Mellitus

Karimi¹

2012

Lipoproteins - Role in Health and Diseases

View full text Add to dashboard Cite

“…2011). Several disease specific knockout and transgenic mouse models are also used, for instance, to study cardiovascular drugs (Avila MD, 2011;Xiangdong L, 2011;Zaragoza C, 2011) and autoimmune disease targeting agents (Gulinello M, 2011;Schroeder MA, 2011). Immunodeficient animals, such as nude, SCID and SCID/NOD tumor xenograft mouse models, are also important for testing and development of new chemotherapeutic drugs (Sausville EA, 2006;Khan N, 2009;Umar A, 2010;Baiocchi M, 2010).…”

Section: Importance Of Preclinical In Vivo Modelsmentioning

confidence: 99%

Pharmacogenomics Dictate Pharmacokinetics: Polymorphisms in Drug-Metabolizing Enzymes and Drug-Transporters

Mondal¹,

Gerlach²,

Datta³

et al. 2012

Readings in Advanced Pharmacokinetics - Theory, Methods and Applications

View full text Add to dashboard Cite

Animal models for the atherosclerosis research: a review

Cited by 124 publications

References 110 publications

Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model

Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model

Animal Models as Tools for Translational Research: Focus on Atherosclerosis, Metabolic Syndrome and Type-II Diabetes Mellitus

Pharmacogenomics Dictate Pharmacokinetics: Polymorphisms in Drug-Metabolizing Enzymes and Drug-Transporters

Contact Info

Product

Resources

About